AUB
ALNY icon

Atlantic Union Bankshares’s Alnylam Pharmaceuticals ALNY Stock Holding History

Atlantic Union Bankshares’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59K Sell
196
-50
-20% -$15.1K ﹤0.01% 895
2026
Q1 		$81.4K Buy
246
+15
+6% +$5.1K ﹤0.01% 793
2025
Q4 		$91.9K Buy
231
+40
+21% +$17.7K ﹤0.01% 773
2025
Q3 		$87.1K Buy
191
+99
+108% +$40.3K ﹤0.01% 795
2025
Q2 		$30K Buy
+92
New +$25.5K ﹤0.01% 749

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atlantic Union Bankshares's ALNY Position: Q2 2026 in Review

Atlantic Union Bankshares reduced its Alnylam Pharmaceuticals (ALNY) stake by 20% in Q2 2026, selling an estimated $15.1K and leaving 196 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Atlantic Union Bankshares first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $91.9K in Q4 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Atlantic Union Bankshares held 196 shares of Alnylam Pharmaceuticals worth $59K as of Q2 2026.
  • Atlantic Union Bankshares sold 50 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $15.1K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #895 holding.
  • Atlantic Union Bankshares first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Atlantic Union Bankshares's Alnylam Pharmaceuticals position peaked at $91.9K in Q4 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.